latest news

News

Tarsus Closes IPO, Starts Phase IIb/III Trials for Demodex Blepharitis Drop

Conni Bergmann Koury / November 18, 2020
News

Exploring Why Pharma Hesitates to Embrace Drug-Delivery Methodologies

News

Equinox Founder Berdahl Moves Sideways, But Not Away, to Keep Company Growing

News

The Next Wave of Glaucoma Innovation: Moving Beyond MIGS

News

COVID Can’t Lock Down Innovation in Glaucoma

Pharmaceuticals & Genetics

Manufacturing Strategy Key to AGTC’s Next Steps for Gene Therapy Programs

August 18, 2020

Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary

August 5, 2020
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

July 9, 2020
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

July 1, 2020
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

April 29, 2020
Adverum, Gene Therapy, and AMD

Adverum, Gene Therapy, and AMD

March 25, 2020

devices & diagnostics

Emerging Glaucoma Devices See Beyond IOP

Emerging Glaucoma Devices See Beyond IOP

May 27, 2020
Soft CL slows myopia in children

Soft CL slows myopia in children

January 22, 2020
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

September 18, 2019
Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

August 28, 2019
How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

August 20, 2019

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Ophthalmic Innovation To Your Inbox.
!
!
!
SUBSCRIBE

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

Subscribe To OIS News

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
!
!
!
Subscribe

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

stay connected

next ois event

about ois

The OIS programs are presented annually by Healthegy, Inc.

Learn more about our world-class conferences.

Listen To The Podcast

OIS-PODCAST--256---[-Daphne-Haim-Landford,-PhD-]---Thumbnail3

Nature as an Inspiration for Innovation

November 18, 2020
OIS Podcast
OIS PODCAST 255 - [ Steven Schwartz, MD ] - Thumbnail

A Lot of Skill and a Little Luck: Dr. Steven Schwartz’s Journey in Ophthalmology Innovation

November 10, 2020
OIS Podcast
OIS-PODCAST---[--Sean-Ianchulev-]---Thumbnail

The Steve Jobs of Ophthalmology

November 3, 2020
OIS Podcast
OIS-PODCAST---[--Joe-Boorady,-OD-]---Thumbnail

Doctor to Doctor with Joe Boorady, OD – President and CEO, Euclid Systems Corporation

October 27, 2020
OIS Podcast
OIS-PODCAST---[-Steve-Pakola]---Thumbnail

Dr. Steve Pakola’s Perspective on the Transformative Power of Advanced Therapeutics

October 20, 2020
OIS Podcast
OIS PODCAST - [ Patrik De Haes, MD ] - Thumbnail

A Stimulating Conversation with Oxurion CEO Patrik De Haes, MD

October 14, 2020
OIS Podcast

Deals

OIS Index Q2

OIS Index Rallies Back from COVID-Driven Decline

July 9, 2020
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

June 10, 2020
AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

May 20, 2020
Covid-19 Impact on Healthcare Company Valuations & Financings

Covid-19 Impact on Healthcare Company Valuations & Financings

April 22, 2020
OIS Index: No Immunity to Coronavirus Selloff

OIS Index: No Immunity to Coronavirus Selloff

April 8, 2020

watch videos from ois tv

OIS Index

OIS Index Rallies Back from COVID-Driven Decline

OIS Index Posts a Strong Finish to 2019

OIS Index Outperforms

OIS Index on Positive Upswing

OIS Index Deep in Bear Territory in Q3

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

ois press

@oistweets

most popular episodes

OIS 1 Year Podcast Anniversary

Year 1: What OIS Podcasts Were Most Popular? Part Two

OIS 1 Year Podcast Anniversary

Year 1: What OIS Podcasts Were Most Popular? Part One

OIS Podcast - Xiidra Prior to Shire: How SARcode Beat the Odds to Create a New Treatment for Dry Eye - Healthegy

Xiidra Prior to Shire: How SARcode Took on the Odds to Pursue a New Treatment for Dry Eye

OIS Podcast | Episode 198

With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?